$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 122.29 | 3,937 | 481,456 | 16,926 | 20.9 K to 16.9 K (-18.87 %) |
Oct 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 20,863 | 16.9 K to 20.9 K (+23.26 %) |
Oct 05 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 110.33 | 172 | 18,977 | 512,845 | 512.7 K to 512.8 K (+0.03 %) |
Oct 05 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 110.33 | 172 | 18,977 | 16,129,099 | 16.1 M to 16.1 M (0.00 %) |
Oct 05 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 110.33 | 172 | 18,977 | 2,943,905 | 2.9 M to 2.9 M (+0.01 %) |
Oct 02 2015 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 110.33 | 147 | 16,219 | 7,802 | 7.7 K to 7.8 K (+1.92 %) |
Oct 02 2015 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Grant | A | 110.33 | 215 | 23,721 | 175,428 | 175.2 K to 175.4 K (+0.12 %) |
Oct 02 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 110.33 | 131 | 14,453 | 258 | 127 to 258 (+103.15 %) |
Sep 23 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 18.32 | 10,000 | 183,200 | 11,709 | |
Sep 23 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Sell | S | 124.29 | 10,000 | 1,242,900 | 62,865 | 72.9 K to 62.9 K (-13.72 %) |
Sep 23 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 18.32 | 10,000 | 183,200 | 72,865 | 62.9 K to 72.9 K (+15.91 %) |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 8.78 | 892,000 | 7,827,300 | 0 | |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 8.78 | 31,967,000 | 280,510,425 | 0 | |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 8.78 | 7,587,000 | 66,575,925 | 0 | |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 8.78 | 65,000 | 570,375 | 0 | |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 8.78 | 64,000 | 561,600 | 0 | |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 0.00 | 101,652 | 0 | 512,673 | 411 K to 512.7 K (+24.73 %) |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 0.00 | 3,642,962 | 0 | 16,128,927 | 12.5 M to 16.1 M (+29.18 %) |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 0.00 | 864,614 | 0 | 2,943,733 | 2.1 M to 2.9 M (+41.59 %) |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 0.00 | 7,406 | 0 | 61,049 | 53.6 K to 61 K (+13.81 %) |
Sep 18 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 0.00 | 7,292 | 0 | 58,632 | 51.3 K to 58.6 K (+14.20 %) |
Sep 18 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 286 | 5,240 | 5,304 | |
Sep 18 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 5,808 | |
Sep 18 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 130.69 | 2,222 | 290,393 | 3,355 | 5.6 K to 3.4 K (-39.84 %) |
Sep 18 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 286 | 5,240 | 5,577 | 5.3 K to 5.6 K (+5.41 %) |
Sep 18 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,291 | 3.4 K to 5.3 K (+57.70 %) |
Sep 15 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 130.00 | 4,301 | 559,130 | 16,926 | 21.2 K to 16.9 K (-20.26 %) |
Sep 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 18,623 | |
Sep 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 118.90 | 3,937 | 468,109 | 21,227 | 25.2 K to 21.2 K (-15.65 %) |
Sep 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 25,164 | 21.2 K to 25.2 K (+18.55 %) |
Aug 17 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 286 | 5,240 | 5,590 | |
Aug 17 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 7,744 | |
Aug 17 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 107.69 | 2,222 | 239,287 | 3,355 | 5.6 K to 3.4 K (-39.84 %) |
Aug 17 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 286 | 5,240 | 5,577 | 5.3 K to 5.6 K (+5.41 %) |
Aug 17 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,291 | 3.4 K to 5.3 K (+57.70 %) |
Aug 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,936 | 72,108 | 22,560 | |
Aug 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 111.95 | 3,936 | 440,635 | 21,227 | 25.2 K to 21.2 K (-15.64 %) |
Aug 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,936 | 72,108 | 25,163 | 21.2 K to 25.2 K (+18.54 %) |
Aug 10 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 18.32 | 2,081 | 38,124 | 5,377 | |
Aug 10 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 17.79 | 6,316 | 112,362 | 0 | |
Aug 10 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 18.32 | 2,081 | 38,124 | 62,857 | 60.8 K to 62.9 K (+3.42 %) |
Aug 10 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 17.79 | 6,316 | 112,362 | 60,776 | 54.5 K to 60.8 K (+11.60 %) |
Jul 16 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | M | 17.79 | 5,000 | 88,950 | 30,354 | |
Jul 16 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | M | 14.72 | 7,850 | 115,552 | 0 | |
Jul 16 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Sell | S | 119.75 | 5,000 | 598,750 | 21,539 | 26.5 K to 21.5 K (-18.84 %) |
Jul 16 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Buy | M | 17.79 | 5,000 | 88,950 | 26,539 | 21.5 K to 26.5 K (+23.21 %) |
Jul 16 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Sell | S | 114.75 | 7,850 | 900,788 | 21,539 | 29.4 K to 21.5 K (-26.71 %) |
Jul 16 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Buy | M | 14.72 | 7,850 | 115,552 | 29,389 | 21.5 K to 29.4 K (+36.45 %) |
Jul 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 286 | 5,240 | 6,449 | |
Jul 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 13,552 | |
Jul 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 113.61 | 2,222 | 252,441 | 3,355 | 5.6 K to 3.4 K (-39.84 %) |
Jul 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 286 | 5,240 | 5,577 | 5.3 K to 5.6 K (+5.41 %) |
Jul 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,291 | 3.4 K to 5.3 K (+57.70 %) |
Jul 16 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 17.79 | 70,217 | 1,249,160 | 0 | |
Jul 16 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 120.00 | 70,217 | 8,426,040 | 21,227 | 91.4 K to 21.2 K (-76.79 %) |
Jul 16 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 17.79 | 70,217 | 1,249,160 | 91,444 | 21.2 K to 91.4 K (+330.79 %) |
Jul 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 26,496 | |
Jul 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 107.00 | 3,937 | 421,259 | 21,227 | 25.2 K to 21.2 K (-15.65 %) |
Jul 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 25,164 | 21.2 K to 25.2 K (+18.55 %) |
Jul 06 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 104.21 | 182 | 18,966 | 411,021 | 410.8 K to 411 K (+0.04 %) |
Jul 06 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 104.21 | 182 | 18,966 | 12,485,965 | 12.5 M to 12.5 M (0.00 %) |
Jul 06 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Grant | A | 104.21 | 182 | 18,966 | 2,079,119 | 2.1 M to 2.1 M (+0.01 %) |
Jul 06 2015 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 104.21 | 155 | 16,153 | 7,655 | 7.5 K to 7.7 K (+2.07 %) |
Jul 06 2015 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Grant | A | 104.21 | 213 | 22,197 | 175,213 | 175 K to 175.2 K (+0.12 %) |
Jul 06 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 104.21 | 127 | 13,235 | 127 | 0 to 127 |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 64.55 | 981 | 63,324 | 17,662 | |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 601 | 9,989 | 2,407 | |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,331 | 121,841 | 30,928 | |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 16,765 | |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 107.84 | 981 | 105,791 | 3,521 | 4.5 K to 3.5 K (-21.79 %) |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 64.55 | 981 | 63,324 | 4,502 | 3.5 K to 4.5 K (+27.86 %) |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 108.28 | 10,710 | 1,159,679 | 3,521 | 14.2 K to 3.5 K (-75.26 %) |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 601 | 9,989 | 14,231 | 13.6 K to 14.2 K (+4.41 %) |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,331 | 121,841 | 13,630 | 6.3 K to 13.6 K (+116.38 %) |
Jun 25 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 6,299 | 3.5 K to 6.3 K (+78.90 %) |
Jun 23 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 17.79 | 20,000 | 355,800 | 70,217 | |
Jun 23 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 108.13 | 20,000 | 2,162,600 | 21,227 | 41.2 K to 21.2 K (-48.51 %) |
Jun 23 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 17.79 | 20,000 | 355,800 | 41,227 | 21.2 K to 41.2 K (+94.22 %) |
Jun 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 287 | 5,258 | 6,162 | |
Jun 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 11,616 | |
Jun 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 105.31 | 2,223 | 234,104 | 3,355 | 5.6 K to 3.4 K (-39.85 %) |
Jun 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 287 | 5,258 | 5,578 | 5.3 K to 5.6 K (+5.42 %) |
Jun 16 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,291 | 3.4 K to 5.3 K (+57.70 %) |
Jun 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 3,937 | 72,126 | 30,433 | |
Jun 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 107.58 | 3,937 | 423,542 | 21,227 | 25.2 K to 21.2 K (-15.65 %) |
Jun 10 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 3,937 | 72,126 | 25,164 | 21.2 K to 25.2 K (+18.55 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 14.72 | 69,132 | 1,017,623 | 0 | |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 14.72 | 127,619 | 1,878,552 | 69,132 | |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.19 | 16,436 | 1,761,775 | 297,518 | 314 K to 297.5 K (-5.24 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.66 | 52,696 | 5,673,251 | 313,954 | 366.7 K to 314 K (-14.37 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 14.72 | 69,132 | 1,017,623 | 366,650 | 297.5 K to 366.7 K (+23.24 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.15 | 22,642 | 2,426,090 | 297,518 | 320.2 K to 297.5 K (-7.07 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.00 | 50,000 | 5,350,000 | 320,160 | 370.2 K to 320.2 K (-13.51 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.36 | 2,358 | 253,155 | 370,160 | 372.5 K to 370.2 K (-0.63 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.00 | 50,000 | 5,350,000 | 372,518 | 422.5 K to 372.5 K (-11.83 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.83 | 2,619 | 282,407 | 422,518 | 425.1 K to 422.5 K (-0.62 %) |
May 28 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 14.72 | 127,619 | 1,878,552 | 425,137 | 297.5 K to 425.1 K (+42.89 %) |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 64.55 | 981 | 63,324 | 18,643 | |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 602 | 10,005 | 3,008 | |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,732 | 128,506 | 38,659 | |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 19,543 | |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 106.00 | 981 | 103,986 | 3,521 | 4.5 K to 3.5 K (-21.79 %) |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 64.55 | 981 | 63,324 | 4,502 | 3.5 K to 4.5 K (+27.86 %) |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 106.43 | 11,112 | 1,182,650 | 3,521 | 14.6 K to 3.5 K (-75.94 %) |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 602 | 10,005 | 14,633 | 14 K to 14.6 K (+4.29 %) |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,732 | 128,506 | 14,031 | 6.3 K to 14 K (+122.75 %) |
May 28 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 6,299 | 3.5 K to 6.3 K (+78.90 %) |
May 27 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
May 27 2015 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
May 27 2015 | INCY | INCYTE CORP | Clancy Paul J | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
May 27 2015 | INCY | INCYTE CORP | DIXON WENDY L | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
May 27 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
May 27 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | A | 107.69 | 15,000 | 1,615,350 | 15,000 | |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 14.72 | 79,592 | 1,171,594 | 196,751 | |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 14.72 | 13,846 | 203,813 | 276,343 | |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 14.72 | 8,805 | 129,610 | 0 | |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.88 | 25,000 | 2,697,000 | 297,518 | 322.5 K to 297.5 K (-7.75 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 107.75 | 25,000 | 2,693,750 | 322,518 | 347.5 K to 322.5 K (-7.19 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 108.50 | 15,200 | 1,649,200 | 347,518 | 362.7 K to 347.5 K (-4.19 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 108.34 | 14,392 | 1,559,229 | 362,718 | 377.1 K to 362.7 K (-3.82 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 14.72 | 79,592 | 1,171,594 | 377,110 | 297.5 K to 377.1 K (+26.75 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 108.92 | 14,388 | 1,567,141 | 297,518 | 311.9 K to 297.5 K (-4.61 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 108.75 | 8,263 | 898,601 | 311,906 | 320.2 K to 311.9 K (-2.58 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 14.72 | 13,846 | 203,813 | 320,169 | 306.3 K to 320.2 K (+4.52 %) |
May 26 2015 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 14.72 | 8,805 | 129,610 | 306,323 | 297.5 K to 306.3 K (+2.96 %) |
May 20 2015 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Option Exercise | A | 7.68 | 20,000 | 153,600 | 0 | |
May 20 2015 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Buy | M | 7.68 | 20,000 | 153,600 | 175,000 | 155 K to 175 K (+12.90 %) |
May 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 286 | 5,240 | 6,449 | |
May 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 18.32 | 1,936 | 35,468 | 13,552 | |
May 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 104.99 | 2,222 | 233,288 | 3,355 | 5.6 K to 3.4 K (-39.84 %) |
May 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 286 | 5,240 | 5,577 | 5.3 K to 5.6 K (+5.41 %) |
May 15 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 18.32 | 1,936 | 35,468 | 5,291 | 3.4 K to 5.3 K (+57.70 %) |
May 12 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 7.68 | 20,000 | 153,600 | 0 | |
May 12 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 7.68 | 20,000 | 153,600 | 0 | |
May 12 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | M | 7.68 | 20,000 | 153,600 | 0 | |
May 12 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 7.68 | 20,000 | 153,600 | 410,839 | 390.8 K to 410.8 K (+5.12 %) |
May 12 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 7.68 | 20,000 | 153,600 | 12,485,783 | 12.5 M to 12.5 M (+0.16 %) |
May 12 2015 | INCY | INCYTE CORP | BAKER JULIAN | Director | Buy | M | 7.68 | 20,000 | 153,600 | 2,078,937 | 2.1 M to 2.1 M (+0.97 %) |
May 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 7,412 | 135,788 | 34,370 | |
May 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 99.43 | 7,412 | 736,975 | 21,227 | 28.6 K to 21.2 K (-25.88 %) |
May 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 7,412 | 135,788 | 28,639 | 21.2 K to 28.6 K (+34.92 %) |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 64.55 | 14,718 | 950,047 | 19,624 | |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 5,556 | 101,786 | 22,321 | |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 15,464 | 257,012 | 46,391 | |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 1,203 | 19,994 | 3,610 | |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 107.67 | 14,718 | 1,584,687 | 3,521 | 18.2 K to 3.5 K (-80.70 %) |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 64.55 | 14,718 | 950,047 | 18,239 | 3.5 K to 18.2 K (+418.01 %) |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 107.67 | 22,223 | 2,392,750 | 3,521 | 25.7 K to 3.5 K (-86.32 %) |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 5,556 | 101,786 | 25,744 | 20.2 K to 25.7 K (+27.52 %) |
Apr 24 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 15,464 | 257,012 | 20,188 | 4.7 K to 20.2 K (+327.35 %) |